# CCNE1 Gene Amplification Might Be Associated with Lymph Node Metastasis of Gastric Cancer

**Authors:** Hinano Nishikubo, Kyoka Kawabata, Tomoya Sano, Saki Kanei, Rika Aoyama, Dongheng Ma, Daiki Imanishi, Takashi Sakuma, Koji Maruo, Yurie Yamamoto, Canfeng Fan, Masakazu Yashiro

PMC · DOI: 10.3390/genes16060617 · Genes · 2025-05-22

## TL;DR

This study finds that CCNE1 gene amplification is linked to lymph node metastasis and worse outcomes in gastric cancer patients.

## Contribution

The study identifies CCNE1 as a novel gene associated with lymph node metastasis in gastric cancer.

## Key findings

- CCNE1-positive patients had significantly more lymph node metastasis compared to CCNE1-negative patients.
- CCNE1 positivity was strongly correlated with postoperative recurrence in gastric cancer patients.
- Stage I gastric cancer patients with CCNE1 amplification had a significantly poorer prognosis.

## Abstract

Background: Lymph node (LN) metastasis is one of the most frequent metastatic patterns in patients with gastric cancer (GC); however, few genes predictive of LN status in GC have been identified. Aims: We aimed to identify candidate genes associated with LN metastasis by analyzing the Center for Cancer Genomics and Advanced Therapeutics (C-CAT) database and performing immunohistochemical analysis of GC cases at our hospital. Patients and Methods: A total of 2028 GCs from the C-CAT database were enrolled to identify genetic alterations. A total of 360 GC patients who underwent gastrectomy at our hospital were enrolled to examine the clinical significance of CCNE1 expression via an immunohistochemical study. Results: A total of 977 cases out of 2028 GC patients showed LN metastasis. Genetic alterations of ERBB2, CCNE1, MYC, ZNF217, and GNAS were frequent in the LN metastasis group. CCNE1-positive expression was found in 108 (30.0%) of the 360 GC samples. LN metastasis was significantly (p = 0.01) more frequent in CCNE1-positive patients. In addition, the CCNE1-positive group had a significantly (p < 0.001) poorer prognosis than the CCNE1-negative group, which was especially evident for GC patients at stage I. CCNE1 positivity was significantly (p < 0.001) correlated with postoperative recurrence. Conclusions: CCNE1 gene amplification is associated with LN metastasis of GC.

## Linked entities

- **Genes:** CCNE1 (cyclin E1) [NCBI Gene 898], ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064], MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609], ZNF217 (zinc finger protein 217) [NCBI Gene 7764], GNAS (GNAS complex locus) [NCBI Gene 2778]
- **Diseases:** gastric cancer (MONDO:0001056)

## Full-text entities

- **Genes:** GNAS (GNAS complex locus) [NCBI Gene 2778] {aka AHO, AIMAH1, C20orf45, GNAS1, GPSA, GSA}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, ZNF217 (zinc finger protein 217) [NCBI Gene 7764] {aka ZABC1}, CCNE1 (cyclin E1) [NCBI Gene 898] {aka CCNE, pCCNE1}, MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}
- **Diseases:** LN metastasis (MESH:D008207), Cancer (MESH:D009369), GC (MESH:D013274)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12191482/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12191482/full.md

## References

21 references — full list in the complete paper: https://tomesphere.com/paper/PMC12191482/full.md

---
Source: https://tomesphere.com/paper/PMC12191482